Clinical trial
Effects of GCP on Prostate Cancer.
NCT00269555 · University of California, Davis, Other · Completed
Key facts
| NCT number | NCT00269555 |
|---|---|
| Title | Effects of GCP on Prostate Cancer. |
| Official title | Effects of a Genistein Combined Polysaccharide (GCP) on Patients With a Diagnosis of Prostate Cancer on Active Surveillance. |
| Lead sponsor | University of California, Davis, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Genistein Combined Polysaccharide (GCP) |
| Enrollment | 62 |
| Start date | May 1, 2004 |
| Primary completion | Jan 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Jun 29, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: